Related Experiment Video
Updated: Aug 15, 2026
06:06
Adjunctive Diode Laser Therapy and Probiotic Lactobacillus Therapy in the Treatment of Periodontitis and Peri-Implant Disease
Published on: May 9, 2022
Desquamative gingivitis: preliminary observations with tetracycline treatment
B A Rønbeck1, P O Lind, P S Thrane
1Department of Oral Surgery and Oral Medicine, Dental Faculty, University of Oslo, Norway.
Oral Surgery, Oral Medicine, and Oral Pathology
|June 1, 1990
Summary
Doxycycline monohydrate effectively treated desquamative gingivitis in fourteen patients. This tetracycline antibiotic significantly improved gingival lesions and mucosal index scores after 6 to 8 weeks of treatment.
Area of Science:
- Oral Medicine
- Dermatology
- Pharmacology
Background:
- Desquamative gingivitis (DG) presents as a clinical manifestation of several underlying conditions, often impacting oral health.
- Accurate diagnosis and effective treatment are crucial for managing DG symptoms and improving patient quality of life.
Purpose of the Study:
- To evaluate the efficacy of doxycycline monohydrate in treating patients diagnosed with desquamative gingivitis.
- To assess the clinical changes and patient-reported symptoms during the treatment period.
Main Methods:
- Fourteen patients with desquamative gingivitis received oral doxycycline monohydrate for 6-8 weeks.
- Gingival lesions were photographed and graded using a four-graded mucosal index system.
- Histologic and immunohistochemical biopsies were performed initially, with regular symptom and clinical change recordings.
Main Results:
- A statistically significant improvement in the mucosal index scores was observed post-treatment.
- Clinical assessment indicated a reduction in the severity of gingival lesions.
- Patient symptoms and mucosal changes were systematically monitored throughout the study.
Conclusions:
- Doxycycline monohydrate demonstrates significant therapeutic efficacy in managing desquamative gingivitis.
- This antibiotic treatment offers a viable option for improving clinical outcomes in DG patients.
- Further research could explore long-term effects and optimal treatment durations.
